Genesis Balanced Portfolio
The Genesis Portfolios are considered a “fund of funds"1. This is an investment approach that uses a strategy of holding a group of funds rather than investing directly in individual stocks, bonds, or other securities. The Genesis Portfolios will invest in a combination of the other Praxis Mutual Funds to achieve the investment objective of the Portfolios. The Portfolios will purchase the Class I shares of each fund. Class I shares are our lowest cost share class. The investment managers may also invest up to 10 percent of each portfolio in non-Praxis mutual funds or exchange traded funds2 to gain exposure to unique investment characteristics not available in the underlying Praxis funds and whose screening criteria may differ from the Everence core stewardship investing guidelines.
Making a difference
Praxis stewardship investing is a values-based approach to socially responsible investing that incorporates:
- Values and ESG-informed restrictive screens
- Corporate engagement strategy
- Values-driven proxy voting policy
- One percent of the fund assets committed to community development investing
Fund performance chart
as of 02/28/2018
|3mon||YTD||1yr||3yr||5yr||Inception (Dec 31, 2009)|
|Praxis Genesis Balanced Portfolio
(without sales charge)
|Praxis Genesis Balanced Portfolio
(with sales charge)
|S&P Target Risk Growth Index (TR)||0.77%||-0.25%||11.65%||6.01%||7.87%||—|
|Praxis Balanced Composite||0.67%||-0.20%||10.28%||6.27%||8.14%||—|
Download the quarterly fact sheet (PDF) for standardized performance.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value will fluctuate so that an investor’s shares, when redeemed may be worth more or less than the original cost.
S&P Target Risk Growth Index seeks to provide increased exposure to equities, while using fixed income to dampen risk. The series is comprised of four multi-asset class indices. The index is comprised exclusively of exchange traded funds.
The composite benchmark is comprised of unmanaged indexes that correspond to the Portfolio’s model allocation. The composite benchmark for each Portfolio consists of: S&P 500 (35.00%), S&P SmallCap 600 (10.00%), MSCI ACWI xUS (15.00%), Bloomberg Barclays Aggregate (40.00%). Indexes are unmanaged, do not incur fees and cannot be invested in directly.
S&P 500 Index is a widely recognized market capitalization weighted index of widely held stocks often used as a proxy for the stock market.
S&P SmallCap 600 Index tracks the performance of the small-cap segment of the U.S. equity market.
MSCI ACWI xUS Index is a market capitalization weighted index that is designed to measure the equity market performance of developed and emerging markets, excluding the United States.
Bloomberg Barclays U.S. Aggregate Index is an index of widely held fixed-income securities often used as a proxy for the bond market. It is comprised of the U.S. Treasury and U.S. agency bonds, mortgage-backed bonds, and higher-grade corporate bonds. Indexes are unmanaged, do not incur fees, and it is not possible to invest directly in an index.
as of 01/31/2018
Top HoldingsSubject to change View all holdings
|PRAXIS IMPACT BOND - I||38.29%|
|PRAXIS INTL INDEX - I||18.92%|
|PRAXIS GROWTH INDEX - I||16.52%|
|PRAXIS VALUE INDEX - I||16.28%|
|PRAXIS SMALL CAP INDEX- I||9.99%|
1 Because each fund in the Genesis Portfolios is a "fund of funds," the cost of investing in a fund may be higher than the cost of investing directly in the shares of the underlying funds in which they invest. Each fund will bear its share of fees and expenses of the underlying funds in addition to indirectly bearing the principal risks of those funds.
2 Exchange traded funds (ETFs) involve additional risks such as the market price trading at a discount to its net asset value, an active secondary trading market may not develop or be maintained, or trading may be halted by the exchange in which they trade, which may impact a fund's ability to sell its shares.
3 Reflects the expense ratio as reported in the prospectus dated April 30, 2017. The Genesis Portfolios invest primarily in other Praxis Funds and is a shareholder of those underlying Funds. The underlying Funds do not charge the Portfolio any sales charge for buying or selling shares. The annual expense charge includes both the Portfolio's direct operating expenses and the indirect expenses of the underlying Funds in which the Portfolio was invested. The net annual expense charge reflects a contractual fee waiver and reimbursement of certain direct expenses of the Portfolio by the fund's advisor through April 30, 2018. See the current prospectus for additional information on expenses.